Post-approval study confirms improved survival with HeartMate II LVAD Healio The data were presented at the International Society for Heart and Lung Transplantation Annual Meeting and Scientific Sessions. The post-approval study included the first 247 HeartMate II users (83% men) ... “Particularly for patients who do not have ... |
